Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis. Issue 2 (February 2014)

• Record Type: Journal Article
• Authors: Crèvecœur, J.; Kaminski, R. M.; Rogister, B.; Foerch, P.; Vandenplas, C.; Neveux, M.; Mazzuferi, M.; Kroonen, J.; Poulet, C.; Martin, D.; Sadzot, B.; Rikir, E.; Klitgaard, H.; Moonen, G.; Deprez, M.
• Is Part Of: Neuropathology & applied neurobiology. Volume 40:Issue 2(2014)
• Page Start: 191
• Page End: 204
• Publication Date: 2014-02
• Subjects: Nervous system -- Diseases -- Pathology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/nan.12054
• Languages: English
• ISSNs: 0305-1846

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="nan12054-sec-0001" sec-type="section"> <title>Aims</title> <p>Synaptic vesicle proteins 2 (SV2) are neuronal vesicles membrane glycoproteins that appear as important targets in the treatment of partial and generalized epilepsies. Therefore, we analysed the expression of SV2 isoforms in the hippocampus of patients with temporal lobe epilepsy (TLE).</p> </sec> <sec id="nan12054-sec-0002" sec-type="section"> <title>Methods</title> <p>SV2A, SV2B and SV2C immunostaining and QuantiGene branched DNA assay were performed on biopsies from 31 consecutive TLE patients with mesial temporal sclerosis (MTS) and compared with 10 autopsy controls. SV2 expression was further compared with Timm's staining, and synaptophysin, Zinc transporter 3 (ZnT3), dynorphin, vesicular glutamate transporter 1 (VGLUT1) and vesicular GABA transporter (VGAT) expression.</p> </sec> <sec id="nan12054-sec-0003" sec-type="section"> <title>Results</title> <p>In TLE patients, SV2A and SV2B expression was decreased in areas of synaptic loss. SV2C, which is weakly expressed or absent in the hippocampus of controls, was overexpressed in 10/11 cases with classical MTS1A and mossy fibre sprouting but not in cases with other types of MTS. SV2C staining was located in the inner molecular layer of the dentate gyrus and colocalized with dynorphin, ZnT3 and VGLUT1, suggesting selective expression in presynaptic glutamatergic Zn<sup>2+</sup>‐rich terminals of abnormal sprouting fibres. SV2 expression patterns correlated with histological subtypes of MTS, but not with clinical features or therapeutic regimens in this patient cohort.</p> </sec> <sec id="nan12054-sec-0004" sec-type="section"> <title>Conclusion</title> <p>In classical MTS1A, the expression of SV2 isoforms is altered with a marked decrease of SV2A and SV2B paralleling synaptic loss and a selective increase of SV2C in sprouting mossy fibres. These findings suggest a different physiology of sprouting synapses and the possibility to target them with SV2C‐specific strategies.</p> </sec> </abstract>